Image via STAT News
Last updated
Enveda: Product Launch
Enveda announced Phase 1 clinical trial results for ENV-308, an oral drug candidate designed to suppress appetite and preserve lean muscle mass by mimicking lactate phenylalanine. Positioned as first leptin sensitizer pill addressing GLP-1 side effects.
Source: STAT News
The leadership read
Enveda's launch shifts talent demand before revenue catches up. In the sector, taking a release to scale rewards product leaders with a commercial edge and operators who build the post-launch motion. Watch whether Enveda backs it with senior go-to-market hires across Americas — that separates a platform move from a one-off.
Market context: Backdrop: a 100.1 (Neutral) Talent Market Index (down 1.1 on the month) with Americas activity easing (-1.8pts).
Enveda: 1 signal in the last 90 days.
More signals across Americas
Product Launch · Americas
Viral Nation →Viral Nation is advising brands and creators on 'AI visibility' as a new deliverable—optimizing creator content to rank in LLM-powered AI search results. The company is positioning creator reviews and social media content as a strategy for brand discoverability in AI chatbot shopping journeys.
Product Launch · Americas
Upwork →Upwork's AI category is growing 22% year-over-year, with significant demand surge for AI-related skills and jobs across their 18M freelancer platform. CEO reports shift toward fractional/contingent work model (38% of US knowledge workers now freelance, up from 28% YoY).
Product Launch · Americas
Regeneron Pharmaceuticals →Regeneron obtained FDA approval for Pasatru, a treatment for fibrodysplasia ossificans progressiva (FOP), an ultra-rare disease causing abnormal bone growth. The approval caps a 30-year development effort.
Product Launch · Americas
Calendly →Calendly launched Callie, a meeting scheduling assistant and note-taker product, entering the competitive AI-powered meeting intelligence market.
Product Launch · Americas
SandboxAQ →SandboxAQ announced general availability of AQPotency, a Large Quantitative Model for drug discovery virtual screening that works without solved protein structures. Product is now available on Claude via Model Context Protocol (MCP).
Product Launch · Americas
Cantor Fitzgerald →Cantor Fitzgerald launched institutional block trading in prediction markets, becoming the first full-service investment bank to offer this service. Initial offering operates on regulated exchange Kalshi with Susquehanna Predictions providing liquidity.
Where this lands in our work
- Enterprise Innovation & Transformation →
A launch is the output of a product and engineering leadership layer built before it.
- Executive Search — Americas →
Our Americas practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗